RT Conference Proceedings
T1 Anti-EGF Antibodies Increase the Effect of ALK and MEK Inhibitors in ALK and KRAS NSCLC and CRC Cell Lines
A1 Garcia-Roman, S.
A1 Codony-Servat, J.
A1 Molina-Vila, M.
A1 Bertran-Alamillo, J.
A1 Gimenez-Capitan, A.
A1 Viteri, S.
A1 Cardona, A.
A1 Rodriguez-Abreu, D.
A1 Cobo Dols, M.
A1 Reguart, N.
A1 Karachaliou, N.
A1 D'Hondt, E.
A1 Rosell, R.
K1 EGF
K1 Vaccine
K1 Immunotherapy
PB Elsevier science inc
SN 1556-0864
YR 2018
FD 2018-10-01
LK https://hdl.handle.net/10668/24368
UL https://hdl.handle.net/10668/24368
LA en
DS RISalud
RD Apr 10, 2025